What should we tackle next in acute myeloid leukemia? Wilms tumor gene 1 vaccine therapy would be a promising and versatile strategy for acute myeloid leukemia

被引：6
作者：
Nakata, Jun [1 ]
Oji, Yusuke [2 ]
Oka, Yoshihiro [3 ]
Sugiyama, Haruo [4 ]
机构：
[1] Osaka Univ, Grad Sch Med, Dept Biomed Informat, 1-7 Yamadaoka, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Med, Dept Funct Diag, Suita, Osaka, Japan
[3] Osaka Univ, Grad Sch Med, Dept Canc Stem Cell Biol, Suita, Osaka, Japan
[4] Osaka Univ, Grad Sch Med, Dept Canc Immunol, Suita, Osaka, Japan
来源：
EXPERT REVIEW OF HEMATOLOGY | 2019年 / 12卷 / 04期
关键词：
Acute myeloid leukemia (AML); Wilms tumor 1 (WT1); cancer vaccine; WT1 vaccine therapy; cancer immunotherapy; WT1 PEPTIDE VACCINATION; STEM-CELL TRANSPLANTATION; PHASE-2; TRIAL; RELAPSE; MALIGNANCIES; RISK;
D O I：
10.1080/17474086.2019.1593824
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：211 / 213
页数：3
相关论文
共 21 条
  • [1] Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia
    Anguille, Sebastien
    Van de Velde, Ann L.
    Smits, Evelien L.
    Van Tendeloo, Viggo F.
    Juliusson, Gunnar
    Cools, Nathalie
    Nijs, Griet
    Stein, Barbara
    Lion, Eva
    Van Driessche, Ann
    Vandenbosch, Irma
    Verlinden, Anke
    Gadisseur, Alain P.
    Schroyens, Wilfried A.
    Muylle, Ludo
    Vermeulen, Katrien
    Maes, Marie-Berthe
    Deiteren, Kathleen
    Malfait, Ronald
    Gostick, Emma
    Lammens, Martin
    Couttenye, Marie M.
    Jorens, Philippe
    Goossens, Herman
    Price, David A.
    Ladell, Kristin
    Oka, Yoshihiro
    Fujiki, Fumihiro
    Oji, Yusuke
    Sugiyama, Haruo
    Berneman, Zwi N.
    [J]. BLOOD, 2017, 130 (15) : 1713 - 1721
  • [2] Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized WT1 Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study
    Cilloni, Daniela
    Renneville, Aline
    Hermitte, Fabienne
    Hills, Robert K.
    Daly, Sarah
    Jovanovic, Jelena V.
    Gottardi, Enrico
    Fava, Milena
    Schnittger, Susanne
    Weiss, Tamara
    Izzo, Barbara
    Nomdedeu, Josep
    van der Heijden, Adrian
    van der Reijden, Bert A.
    Jansen, Joop H.
    van der Velden, Vincent H. J.
    Ommen, Hans
    Preudhomme, Claude
    Saglio, Giuseppe
    Grimwade, David
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (31) : 5195 - 5201
  • [3] Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
    DiNardo, Courtney D.
    Pratz, Keith
    Pullarkat, Vinod
    Jonas, Brian A.
    Arellano, Martha
    Becker, Pamela S.
    Frankfurt, Olga
    Konopleva, Marina
    Wei, Andrew H.
    Kantarjian, Hagop M.
    Xu, Tu
    Hong, Wan-Jen
    Chyla, Brenda
    Potluri, Jalaja
    Pollyea, Daniel A.
    Letai, Anthony
    [J]. BLOOD, 2019, 133 (01) : 7 - 17
  • [4] Acute myeloid leukemia: 2019 update on risk-stratification and management
    Estey, Elihu H.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (10) : 1267 - 1291
  • [5] WT1 peptide vaccination following allogeneic stem cell transplantation in pediatric leukemic patients with high risk for relapse: successful maintenance of durable remission
    Hashii, Y.
    Sato-Miyashita, E.
    Matsumura, R.
    Kusuki, S.
    Yoshida, H.
    Ohta, H.
    Hosen, N.
    Tsuboi, A.
    Oji, Y.
    Oka, Y.
    Sugiyama, H.
    Ozono, K.
    [J]. LEUKEMIA, 2012, 26 (03) : 530 - 532
  • [6] Vaccination strategies to improve outcome of hematopoietic stem cell transplant in leukemia patients: early evidence and future prospects
    Hosen, Naoki
    Maeda, Tetsuo
    Hashii, Yoshiko
    Tsuboi, Akihiro
    Nishida, Sumiyuki
    Nakata, Jun
    Nakae, Yoshiki
    Takashima, Satoshi
    Oji, Yusuke
    Oka, Yoshihiro
    Kumanogoh, Atsushi
    Sugiyama, Haruo
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (05) : 671 - 681
  • [7] WT1 AS A NEW PROGNOSTIC FACTOR AND A NEW MARKER FOR THE DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE-LEUKEMIA
    INOUE, K
    SUGIYAMA, H
    OGAWA, H
    NAKAGAWA, M
    YAMAGAMI, T
    MIWA, H
    KITA, K
    HIRAOKA, A
    MASAOKA, T
    NASU, K
    KYO, T
    DOHY, H
    NAKAUCHI, H
    ISHIDATE, T
    AKIYAMA, T
    KISHIMOTO, T
    [J]. BLOOD, 1994, 84 (09) : 3071 - 3079
  • [8] A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS
    Keilholz, Ulrich
    Letsch, Anne
    Busse, Antonia
    Asemissen, Anne Marie
    Bauer, Sandra
    Blau, Igor Wolfgang
    Hofmann, Wolf-Karsten
    Uharek, Lutz
    Thiel, Eckhard
    Scheibenbogen, Carmen
    [J]. BLOOD, 2009, 113 (26) : 6541 - 6548
  • [9] A new peptide vaccine OCV-501: in vitro pharmacology and phase 1 study in patients with acute myeloid leukemia
    Kobayashi, Yukio
    Sakura, Toru
    Miyawaki, Shuichi
    Toga, Kazuyuki
    Sogo, Shinji
    Heike, Yuji
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (07) : 851 - 863
  • [10] Maintenance of complete remission after allogeneic stem cell transplantation in leukemia patients treated with Wilms tumor 1 peptide vaccine
    Maeda, T.
    Hosen, N.
    Fukushima, K.
    Tsuboi, A.
    Morimoto, S.
    Matsui, T.
    Sata, H.
    Fujita, J.
    Hasegawa, K.
    Nishida, S.
    Nakata, J.
    Nakae, Y.
    Takashima, S.
    Nakajima, H.
    Fujiki, F.
    Tatsumi, N.
    Kondo, T.
    Hino, M.
    Oji, Y.
    Oka, Y.
    Kanakura, Y.
    Kumanogoh, A.
    Sugiyama, H.
    [J]. BLOOD CANCER JOURNAL, 2013, 3 : e130 - e130
123